| Name | 3-bromo-8-methylsulfanylimidazo[1,2-a]pyrazine |
|---|
| Molecular Formula | C7H6BrN3S |
|---|---|
| Molecular Weight | 244.11200 |
| Exact Mass | 242.94700 |
| PSA | 55.49000 |
| LogP | 2.21370 |
| HS Code | 2933990090 |
|---|
|
~95%
887475-39-0 |
| Literature: Belanger, David B.; Curran, Patrick J.; Hruza, Alan; Voigt, Johannes; Meng, Zhaoyang; Mandal, Amit K.; Siddiqui, M. Arshad; Basso, Andrea D.; Gray, Kimberly Bioorganic and Medicinal Chemistry Letters, 2010 , vol. 20, # 17 p. 5170 - 5174 |
|
~78%
887475-39-0 |
| Literature: Oncotherapy Science, Inc. Patent: US2012/59162 A1, 2012 ; Location in patent: Page/Page column 38-39 ; |
|
~56%
887475-39-0 |
| Literature: BioMarin IGA, Ltd.; WREN, Stephen Paul; WYNNE, Graham Michael; LECCI, Cristina; WILSON, Francis Xavier; PRICE, Paul Damien; MIDDLETON, Penny Patent: WO2010/69684 A1, 2010 ; Location in patent: Page/Page column 97-98 ; |
|
~%
887475-39-0 |
| Literature: Oncotherapy Science, Inc. Patent: US2012/59162 A1, 2012 ; |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |